SCHEMBL30488261

SCHEMBL30488261

CC(C)Oc1ccc(CO)cc1C(F)(F)F

nearest known ligand 0.59

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.59
RXRB P28702 1/20 0.59
RXRG P48443 1/20 0.59
S1PR1 P21453 11/20 0.42
AR P10275 1/20 0.42
CTSS P25774 1/20 0.42
CTSK P43235 1/20 0.42
S1PR5 Q9H228 3/20 0.41
S1PR3 Q99500 2/20 0.41
P2RX3 P56373 1/20 0.41
TRPV1 Q8NER1 1/20 0.41
CSNK2A1 P68400 2/20 0.41
KIF11 P52732 1/20 0.41
KCNH2 Q12809 1/20 0.40
S1PR4 O95977 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2019451 1.00 RXRA (0.59) RXRARXRBRXRGS1PR1AR
SCHEMBL2328507 0.88 RXRA (0.47) RXRARXRBRXRGS1PR1AR
SCHEMBL14328002 0.85 RXRA (0.57) RXRARXRBRXRGS1PR1CTSS
SCHEMBL26291337 0.85 RXRA (0.44) RXRARXRBRXRGS1PR1AR
SCHEMBL932902 0.84 RXRA (0.56) RXRARXRBRXRGS1PR1CTSS
SCHEMBL2415055 0.84 RXRA (0.59) RXRARXRBRXRGS1PR1CTSS
SCHEMBL247961 0.84 CSNK2A1 (0.59) RXRARXRBRXRGS1PR1CTSS
SCHEMBL26179843 0.83 RXRA (0.54) RXRARXRBRXRGS1PR1CTSS
SCHEMBL10088920 0.83 RXRA (0.42) RXRARXRBRXRGS1PR1AR
SCHEMBL1437536 0.81 S1PR1 (0.58) RXRARXRBRXRGS1PR1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4444697-A1 CARBOXYLIC ACID CONTAINING INDANYL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES CELGENE CORPORATION (US) 2024-10-16 EP disclosed
CN-118632834-A Indanyl compounds containing carboxylic acids for the treatment of neurodegenerative diseases 细胞基因公司 2024-09-10 CN disclosed
WO-2023107563-A1 CARBOXYLIC ACID CONTAINING INDANYL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES CELGENE CORPORATION (US) 2023-06-15 WO disclosed